The Johns Hopkins University School of Medicine is the medical school of Johns Hopkins University, a private research university in Baltimore, Maryland. Founded in 1893, the School of Medicine shares a campus with the Johns Hopkins Hospital and Johns Hopkins Children's Center, established in 1889.

During the past decade, Johns Hopkins University School of Medicine conducted 279 clinical trials. In the 10-year time frame, 279 clinical trials started and 144 clinical trials were completed, i.e. on average, 51.6% percent of trials that started reached the finish line to date. In the past 5 years, 132 clinical trials started and 83 clinical trials were completed. i.e. 62.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johns Hopkins University School of Medicine" #1 sponsor was "Johns Hopkins University" with 144 trials, followed by "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" with 19 trials sponsored, "Centers for Disease Control and Prevention" with 12 trials sponsored, "Alexion" with 9 trials sponsored and "Bristol-Myers Squibb" with 9 trials sponsored. Other sponsors include 337 different institutions and companies that sponsored additional 224 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johns Hopkins University School of Medicine" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 23 trials as a collaborator, "Johns Hopkins University" with 22 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 12 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 11 trials as a collaborator and "National Institutes of Health (NIH)" with 11 trials as a collaborator. Other collaborators include 349 different institutions and companies that were collaborators in the rest 241 trials.

According to Clinical.Site data, the most researched conditions in "Johns Hopkins University School of Medicine" are "HIV Infections" (25 trials), "Amyotrophic Lateral Sclerosis" (11 trials), "Tuberculosis" (11 trials), "Prostate Cancer" (9 trials) and "Parkinson Disease" (8 trials). Many other conditions were trialed in "Johns Hopkins University School of Medicine" in a lesser frequency.

Most popular intervention types in "Johns Hopkins University School of Medicine" are "Drug" (309 trials), "Behavioral" (56 trials), "Other" (54 trials), "Device" (46 trials) and "Biological" (34 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (82 trials), "Atezolizumab" (6 trials), "Nivolumab" (5 trials), "Rifabutin" (5 trials) and "eculizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Johns Hopkins University School of Medicine" are 487 trials for "All" genders, 30 trials for "Female" genders and 18 trials for "Male" genders.

Currently, there are 157 active trials in "Johns Hopkins University School of Medicine". 7 are not yet recruiting, 93 are recruiting, 44 are Active, not recruiting, and 13 are Enrolling by invitation. In total, there were 304 completed trials in Johns Hopkins University School of Medicine, 3 suspended trials, and 51 terminated clinical trials to date.

Out of the total trials that were conducted in Johns Hopkins University School of Medicine, 65 "Phase 1" clinical trials were conducted, 160 "Phase 2" clinical trials and 106 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 17 trials, and there were also 119 trials that are defined as “Not Applicable".

Johns Hopkins University School of Medicine has several departments that took part in Clinical trials: "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" - 10 trials, "Behavioral Pharmacology Research Unit" - 77 trials, "Johns Hopkins Children's Center" - 52 trials, "Medicine Branch" - 32 trials, "Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases" - 20 trials, "The Center for Learning and Health" - 15 trials, "Johns Hopkins Hospital - Medicine - Infectious Diseases" - 13 trials, "Johns Hopkins University, Department of Neurology" - 9 trials, "Suburban Hospital Cancer Program" - 9 trials, "Johns Hopkins Bayview Medical Center - Infectious Diseases" - 9 trials, "Harriet Lane Clinic" - 8 trials, "Johns Hopkins Dept. of Dermatology" - 7 trials, "NIH Heart Center at Suburban Hospital" - 7 trials, "The Bunting Blaustein Cancer Research Building" - 6 trials, "Cardiovascular Specialists of Central Maryland" - 5 trials, "Brady Urological Institute, Johns Hopkins Hospital" - 4 trials, "Johns Hopkins Pediatric Diabetes Center" - 4 trials, "The Johns Hopkins Bayview Headache Center" - 4 trials, "Johns Hopkins Investigational Drug Service" - 4 trials, "Johns Hopkins University Pulmonary and Critical Care Medicine" - 4 trials, "Johns Hopkins Hospital Pediatric Clinical Research Unit" - 4 trials, "Johns Hopkins School of Medicine Division of Pediatric Nephrology" - 3 trials, "Department of Surgery, Johns Hopkins University School of Medicine" - 3 trials, "Cutaneous Translational Research Program, Department of Dermatology, Johns Hopkins University School of Medicine" - 3 trials